6-K ·Filed Aug 3, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001654954-26-007169
Actionable Insight • Neutral

This is a routine employee share issuance with negligible dilution. No impact on fundamental valuation. Monitor upcoming earnings or pipeline catalysts for directional moves.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
AZN ▲ +2.47% at T+20d
NEUTRAL call ✓ call won +2.47% · α vs SPY +1.23% · entry $157.97 → $161.87
Next anchor: T+60d in 25d
Latest observation: T+39 +14.55% FF3 residual α
Entry anchored
Aug 3, 10:44 AM ET
via exchange tick
T+1d
-1.65%
call -1.65% · α -3.43%
$155.36
settled 8w ago
T+5d
+2.30%
call +2.30% · α +0.27%
$161.61
settled 8w ago
T+20d
+2.47%
call +2.47% · α +1.23%
$161.87
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

AstraZeneca filed a routine 6-K notification of admission of 8,855 ordinary shares under its employee share schemes, issued between 1 July and 31 July 2026 under a block admission from January 2021. The total shares outstanding increased to 1,551,033,389, representing negligible dilution of ~0.00057%. This is an administrative filing with no material impact on the company's financials or stock price.

Key Facts

  • AstraZeneca admitted 8,855 ordinary shares under employee share schemes
  • Total shares outstanding after admission: 1,551,033,389
  • Issued between 1 July 2026 and 31 July 2026 under block admission dated 29 January 2021

Financial Impact

Immaterial - 8,855 shares issued under employee schemes, representing 0.00057% dilution on total shares outstanding of 1,551,033,389

dilution

Risk Factors

  • No material risk from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (AZN) — Batch item 10001654954-26-007169
Document: 0001654954-26-007169-index-headers.html0001654954-26-007169
Document: 0001654954-26-007169-index.html0001654954-26-007169
Document: 0001654954-26-007169.txt0001654954-26-007169
6-K Filing (AZN) — Batch item 50001654954-26-007169
Document: 0001654954-26-007169-index-headers.html0001654954-26-007169
Document: 0001654954-26-007169-index.html0001654954-26-007169
Document: 0001654954-26-007169.txt0001654954-26-007169
54 reports for AZN
Performance horizon
67% Hit rate 20 of 30 directional calls best @ T+60▲ +13.65%Jul 6, 2026
Filters
Rows
Reports for AZN — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$161.85 $168.37▲ +4.03%▲ +1.90%$157.02 (−2.98%)
Sep 14, 2026
18d ago
6-K
BEARISH ★ 5/10
$163.78 $168.10▼ −2.64%▼ −2.53%$157.02 (+4.13%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 7/10
$160.04 $161.85▲ +1.13%▲ +2.25%$157.02 (−1.89%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$157.02 (−3.20%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$157.02 (−3.20%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$162.47 $156.94▼ −3.40%▼ −3.49%$157.02 (−3.35%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.22 $156.94▼ −3.25%▼ −3.33%$157.02 (−3.20%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$162.22 $156.94▼ −3.25%▼ −3.33%$157.02 (−3.20%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.47 $156.94▼ −3.40%▼ −3.49%$157.02 (−3.35%)
Aug 31, 2026
4w ago
Court Ruling
BEARISH ★ 3/10
$162.13 $159.95▲ +1.34%▲ +1.20%$157.02 (+3.15%)
Showing 10 of 54

US Market Status

Market Open — Closes in 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access